
TSI GROUP CO., LTD. — Investor Relations & Filings
TSI Group Co., Ltd. is a global developer and manufacturer of functional ingredients and finished dosage forms for the dietary supplement, pharmaceutical, and food and beverage sectors. The company specializes in the research, development, and large-scale production of high-quality bioactive compounds. Key product categories include joint health ingredients such as glucosamine and chondroitin, as well as proprietary muscle health and metabolic health solutions like HMB and PEAK ATP. TSI Group maintains advanced manufacturing facilities and quality control systems to ensure compliance with international standards. The organization focuses on providing science-based ingredients supported by clinical research to global brand owners and manufacturers. Its core capabilities span from raw material sourcing and chemical synthesis to specialized formulation and finished product manufacturing.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 技源集团股份有限公司2025年年度股东会会议资料 | 2026-05-22 | Chinese | |
| 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-15 | Chinese | |
| 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-11 | Chinese | |
| 技源集团股份有限公司关于回购股份事项前十大股东和前十大无限售条件股东持股情况的报告 | 2026-05-07 | Chinese | |
| 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-07 | Chinese | |
| 技源集团2025年度报告摘要 | 2026-04-27 | Chinese |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46868153 | 技源集团股份有限公司2025年年度股东会会议资料 | 2026-05-22 | Chinese | ||
| 46364759 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-15 | Chinese | ||
| 45016886 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-11 | Chinese | ||
| 44267612 | 技源集团股份有限公司关于回购股份事项前十大股东和前十大无限售条件股东持股情况的报告 | 2026-05-07 | Chinese | ||
| 44267577 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-07 | Chinese | ||
| 39593617 | 技源集团2025年度报告摘要 | 2026-04-27 | Chinese | ||
| 39593616 | 东方证券股份有限公司关于技源集团股份有限公司2025年度日常关联交易执行情况和2026年度日常关联交易预计的核查意见 | 2026-04-27 | Chinese | ||
| 39593612 | 技源集团关于使用部分闲置募集资金进行现金管理的公告 | 2026-04-27 | Chinese | ||
| 39593607 | 技源集团2025年度董事会审计委员会履职报告 | 2026-04-27 | Chinese | ||
| 39593602 | 技源集团关于2026年第一季度主要经营数据公告 | 2026-04-27 | Chinese | ||
| 39593600 | 技源集团关于2025年度日常关联交易执行情况和2026年度日常关联交易预计的公告 | 2026-04-27 | Chinese | ||
| 39593599 | 技源集团关于召开2025年年度股东会的通知 | 2026-04-27 | Chinese | ||
| 39593596 | 东方证券股份有限公司关于技源集团股份有限公司2025年度持续督导现场检查报告 | 2026-04-27 | Chinese | ||
| 39593588 | 技源集团关于公司使用部分自有资金进行投资理财的公告 | 2026-04-27 | Chinese | ||
| 39593578 | 技源集团关于2025年度计提资产减值准备的公告 | 2026-04-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
TSI GROUP CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57547/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57547 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57547 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57547 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57547}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TSI GROUP CO., LTD. (id: 57547)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.